Filter
13273
Filtered Results: 13273
Text search:
status
Featured
Recommendations
1047
New Publications
3360
Language
Document type
No document type
7239
Studies & Reports
2366
Guidelines
1569
Manuals
654
Strategic & Response Plan
450
Fact sheets
402
Training Material
246
Situation Updates
152
Infographics
68
Resource Platforms
59
Brochures
38
Dashboards/Maps
13
Online Courses
11
Videos
5
App
1
Countries / Regions
Global
576
India
545
Kenya
344
Ethiopia
261
Nigeria
255
Sierra Leone
247
South Africa
247
Western and Central Europe
242
Nepal
234
Uganda
231
Liberia
220
Myanmar / Burma
214
Indonesia
198
Latin America and the Carribbean
191
Africa
190
Rwanda
180
Malawi
173
Tanzania
172
Germany
171
Zambia
170
Bangladesh
169
Syria
166
Ukraine
145
Congo, Democratic Republic of
136
Ghana
134
Namibia
128
South Sudan
115
Philippines
107
Senegal
103
Brazil
101
Lesotho
92
Zimbabwe
91
Eastern Europe
91
Guinea
83
Venezuela
82
Russia
82
Mozambique
78
Cambodia
78
South–East Asia Region
78
West and Central Africa
76
Haiti
75
East and Southern Africa
74
Yemen
71
Asia
70
Middle East and North Africa
67
Burkina Faso
60
Cameroon
52
Botswana
48
Afghanistan
42
Colombia
41
Benin
40
Eastern Europe and Central Asia
40
Eswatini/ Swaziland
40
Pakistan
39
Sudan
37
Central African Republic
33
Somalia
31
Lebanon
30
USA
27
Paraguay
27
Madagascar
27
Jordan
25
Mali
25
Vietnam
24
Thailand
23
China
22
Western Pacific Region
22
Peru
21
Tajikistan
20
Chile
17
Moldova
17
Sri Lanka
17
Iraq
17
Côte d’Ivoire / Ivory Coast
16
Angola
16
Albania
15
Laos
15
Argentina
15
North America
14
Ecuador
14
Turkey
13
Togo
12
Niger
12
Greece
12
Georgia
12
Libya
12
Bolivia
11
North Macedonia
10
Iran
10
Burundi
10
Spain
10
Palestine
10
Chad
10
Mexico
9
Kyrgyzstan
9
Italy
9
United Kingdom
9
Southern Africa
9
Papua New Guinea
9
Egypt
9
El Salvador
8
Kazakhstan
8
Armenia
8
Hungary
8
Serbia
7
Guinea-Bissau
7
Saudi Arabia
7
Portugal
7
Romania
7
Poland
7
Timor Leste/ East Timor
6
Jamaica
6
Belarus
6
Switzerland
5
Turkmenistan
5
Tunisia
5
Bhutan
5
Gambia
4
Estonia
4
Malaysia
4
Morocco
4
Dominican Republic
4
Croatia
4
Guatemala
4
Canada
3
Fiji
3
Uzbekistan
3
Mongolia
3
Qatar
3
Mauritania
3
Japan
3
France
3
Mauritius
3
Azerbaijan
3
Israel
3
Bosnia and Herzegovina
3
Guyana
3
Djibouti
3
Honduras
3
North Korea
2
Australia
2
Singapore
2
Bulgaria
2
Lithuania
2
Ireland
2
Gabon
2
Slovakia
2
Cuba
2
Congo-Brazzaville
1
Austria
1
Vanuatu
1
Cape Verde
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Latvia
1
Slovenia
1
Barbados
1
Eritrea
1
Oman
1
Nicaragua
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
5033
Clinical Guidelines
844
Key Resources
685
Women & Child Health
649
Public Health
641
Capacity Building
270
Pharmacy & Technologies
131
Annual Report MEDBOX
3
Toolboxes
COVID-19
1154
HIV
999
Mental Health
953
TB
616
Disability
496
Planetary Health
482
Conflict
400
Refugee
394
NTDs
384
Ebola & Marburg
361
Caregiver
327
AMR
311
NCDs
241
Rapid Response
239
Global Health Education
214
Pharmacy
191
Health Financing Toolbox
175
Natural Hazards
166
Malaria
152
Zika
131
2.0 Rapid Response
129
Social Ethics
97
Cholera
79
Polio
77
Specific Hazards
72
Typhoon
6
South Sudan
3
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
At each point reinforce advice about diet and life...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil...
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biological materials as part of this international exchange system should abide, to ensure safe and secure operations. These provisions are in accordance wit...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
Identification of Priority Areas for Multisectoral Interventions (PAMIs) for cholera control
recommended
The identification of Priority Areas for Multisectoral Interventions (PAMIs, sometimes referred to as ‘hotspots’) for cholera control is among the first steps for a cholera-affected country to develop or revise a National Cholera Plan (NCP) for cholera control. PAMI identification is critical to...
